Cargando…
A genetic risk assessment for prostate cancer influences patients’ risk perception and use of repeat PSA testing: a cross-sectional study in Danish general practice
BACKGROUND: Prostate cancer (PC) is the most common cancer among men in the western world. Genetic lifetime risk assessment could alleviate controversies about prostate specific antigen (PSA) testing for early diagnosis. AIM: To determine how men interpret information about their lifetime risk for P...
Autores principales: | Fredsøe, Jacob, Kirkegaard, Pia, Edwards, Adrian, Vedsted, Peter, Sørensen, Karina Dalsgaard, Bro, Flemming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal College of General Practitioners
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330221/ https://www.ncbi.nlm.nih.gov/pubmed/32457098 http://dx.doi.org/10.3399/bjgpopen20X101039 |
Ejemplares similares
-
The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trial
por: Fredsøe, Jacob, et al.
Publicado: (2020) -
A cluster-randomised, parallel group, controlled intervention study of genetic prostate cancer risk assessment and use of PSA tests in general practice—the ProCaRis study: study protocol
por: Kirkegaard, Pia, et al.
Publicado: (2013) -
Perceptions about screening for prostate cancer using genetic lifetime risk assessment: a qualitative study
por: Kirkegaard, Pia, et al.
Publicado: (2018) -
Cost-Effectiveness Analysis of Stockholm 3 Testing Compared to PSA as the Primary Blood Test in the Prostate Cancer Diagnostic Pathway: A Decision Tree Approach
por: Risør, Bettina Wulff, et al.
Publicado: (2022) -
Danish Prostate Cancer Consortium Study 1 (DPCC-1) protocol: Multicentre prospective validation of the urine-based three-microRNA biomarker model uCaP
por: Fredsøe, Jacob, et al.
Publicado: (2023)